TCRX

TScan Therapeutics (TCRX)

TScan Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TCRX

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/13	20:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TCRX	TScan Therapeutics Inc
2024/05/13	20:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2024/05/13	20:00	GlobeNewswire Inc.	TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:TCRX	TScan Therapeutics Inc
2024/05/09	20:00	GlobeNewswire Inc.	TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/25	05:05	GlobeNewswire Inc.	TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/25	00:03	GlobeNewswire Inc.	TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/23	06:01	GlobeNewswire Inc.	TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/19	23:05	GlobeNewswire Inc.	TScan Therapeutics Announces Closing of Upsized Public Offering	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/17	13:30	GlobeNewswire Inc.	TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/17	05:25	GlobeNewswire Inc.	TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/17	05:01	GlobeNewswire Inc.	TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/08	21:00	GlobeNewswire Inc.	TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer	NASDAQ:TCRX	TScan Therapeutics Inc
2024/04/02	20:00	GlobeNewswire Inc.	TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:TCRX	TScan Therapeutics Inc
2024/03/07	06:11	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:TCRX	TScan Therapeutics Inc
2024/03/07	06:05	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TCRX	TScan Therapeutics Inc
2024/03/06	21:30	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:TCRX	TScan Therapeutics Inc
2024/03/06	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2024/02/15	06:45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TCRX	TScan Therapeutics Inc
2024/01/29	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2023/12/11	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2023/12/07	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2023/11/09	21:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TCRX	TScan Therapeutics Inc
2023/11/09	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2023/08/29	21:02	Dow Jones News	TScan Gets FDA Clearance of Investigational New Drug Application for Cancer Treatment	NASDAQ:TCRX	TScan Therapeutics Inc
2023/08/10	20:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TCRX	TScan Therapeutics Inc
2023/08/10	20:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc
2023/07/25	08:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TCRX	TScan Therapeutics Inc
2023/07/25	08:31	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:TCRX	TScan Therapeutics Inc
2023/06/29	21:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TCRX	TScan Therapeutics Inc
2023/06/29	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCRX	TScan Therapeutics Inc